Assignee
PROLX PHARMACEUTICALS CORP
US·5 granted patents·1 pending application·56 citations·filing 1998–2010
Top patents by PatentIndex Score
6 records- 0188US7446124B2Wortmannin analogs and methods of using same in combination with chemotherapeutic agentsPROLX PHARMACEUTICALS CORP·Filed 2005·Granted Nov 4, 2008·12 cites·25 claims
- 0283US7399785B2N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factorPROLX PHARMACEUTICALS CORP·Filed 2004·Granted Jul 15, 2008·18 cites·19 claims
- 0381US7858657B2Wortmannin analogs and methods of using same in combination with chemotherapeutic agentsPROLX PHARMACEUTICALS CORP·Filed 2008·Granted Dec 28, 2010·1 cites·8 claims
- 0462US7629128B2Methods of identifying respondents to hypoxia inducible factor 1-α inhibitorsPROLX PHARMACEUTICALS CORP·Filed 2006·Granted Dec 8, 2009·1 cites·5 claims
- 0560US6372772B1Inhibitors of redox signaling and methods of using samePROLX PHARMACEUTICALS CORP·Filed 1998·Granted Apr 16, 2002·24 cites·4 claims
- 0656US2011110941A1Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic AgentsPROLX PHARMACEUTICALS CORP·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →